Related Experiment Videos
Corynebacterium group JK peritonitis in patients on continuous ambulatory peritoneal dialysis
Klinische Wochenschrift
|August 16, 1984
Abstract:
Corynebacterium group JK is described as the aetiologic agent of a second episode of peritonitis which occurred after a period of antibiotic treatment for likely endogenous peritonitis. Inclusion of vancomycin is suggested for treatment of continuous ambulatory peritoneal dialysis (CAPD) peritonitis in patients colonized by these multiresistant bacteria.
Insights
Multiresistant Corynebacterium group JK can cause recurrent peritonitis in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Vancomycin is recommended for treating CAPD peritonitis caused by these resistant bacteria.
Area of Science:
- Infectious Diseases
- Nephrology
- Microbiology
Background:
- Peritonitis is a serious complication for patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
- Recurrent peritonitis poses significant treatment challenges, especially with antibiotic-resistant organisms.
Observation:
- A second episode of peritonitis was identified in a CAPD patient.
- The causative agent was identified as Corynebacterium group JK, a multiresistant bacterium.
- The initial peritonitis episode was likely endogenous and treated with antibiotics.
Findings:
- Corynebacterium group JK was confirmed as the etiological agent for the recurrent peritonitis.
- The bacteria exhibited multiresistance to common antibiotics.
- This highlights the potential for endogenous peritonitis to be followed by resistant bacterial infections.
Implications:
- Vancomycin inclusion in treatment regimens is suggested for CAPD peritonitis when Corynebacterium group JK colonization is present.
- This recommendation aims to improve treatment outcomes for resistant bacterial peritonitis in CAPD patients.
- Further research into the management of multiresistant bacterial infections in CAPD patients is warranted.